Taiwanese Pharmaceuticals & Biotech High And Sustainable

Results

0 new

Companies in a sound financial shape with a dividend yield of more than 5%.

4 companies

TSH Biopharm

Market Cap: NT$1.9b

Develops and markets pharmaceutical products in Taiwan.

8432

NT$50.60

1.2%

3.0%

Allied Biotech

Market Cap: NT$2.7b

Engages in the manufacture and sale of carotenoids worldwide.

1780

NT$24.85

0.2%

43.6%

TTY Biopharm

Market Cap: NT$19.4b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

4105

NT$78.20

1.6%

SYN-TECH Chem. & Pharm

Market Cap: NT$3.3b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

1777

NT$74.00

-0.1%

-2.2%